The impact on clinical success from the 23andMe cohort
Xin Wang, Sotiris Karagounis, Suyash Shringarpure, Rohith Srivas, Qiaojuan Jane Su, Vladimir Vacic, Steven J. Pitts, Adam Auton
This paper evaluates how the scale and quality of genetic data from the 23andMe cohort improve predictions of clinical success for drug targets.
medRxiv · Jun 17, 2024 · PreprintGenetic & Genomic Medicine